Detecting Novel Urine Biomarkers for the Early Diagnosis of Prostate Cancer: Platelet Derived Growth Factor-BB as a Possible New Target | Zendy

Athanasios Skarmoutsos | Zendy; Ioannis Skarmoutsos | Zendy; Ioannis Katafigiotis | Zendy; Elisavet Tataki | Zendy; Athina Giagini | Zendy; Christos Alamanis | Zendy; Ioannis Anastasiou | Zendy; Anastasios Angelou | Zendy; Mordechai Duvdevani | Zendy; Nikolaos M. Sitaras | Zendy; Constantinos Constantinides | Zendy

Open Access

Detecting Novel Urine Biomarkers for the Early Diagnosis of Prostate Cancer: Platelet Derived Growth Factor-BB as a Possible New Target

Author(s) -

Athanasios Skarmoutsos,

Ioannis Skarmoutsos,

Ioannis Katafigiotis,

Elisavet Tataki,

Athina Giagini,

Christos Alamanis,

Ioannis Anastasiou,

Anastasios Angelou,

Mordechai Duvdevani,

Nikolaos M. Sitaras,

Constantinos Constantinides

Publication year - 2018

Publication title -

current urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.476

H-Index - 13

eISSN - 1661-7657

pISSN - 1661-7649

DOI - 10.1159/000447225

Subject(s) - medicine , prostate cancer , urine , receiver operating characteristic , biomarker , prostate specific antigen , prostate biopsy , platelet derived growth factor receptor , prostate , urology , pca3 , cancer , growth factor , pathology , biochemistry , chemistry , receptor

Although the prostate specific antigen revolutionized the diagnosis of prostate cancer (PCa), it has its limitations. We prospectively examined the potential use of the platelet-derived growth factor-BB (PDGF-BB) as a urine biomarker for the early diagnosis of PCa.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research